Liminatus Pharma LIMN Growth Metrics (2024-2026)

NASDAQ LIMN
$3.91 -0.36 (-8.43%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

Liminatus Pharma Quarterly Growth Metrics

Periods 8 quarters
Latest Jun 2026

Liminatus Pharma growth metrics data for the quarter ended Jun 2026. These growth metrics cover 8 quarters of results from Sep 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Growth Metrics Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Growth Ratios
Interest Coverage Ratio Growth (1y)Interest Cover Growth (1y) -52.47%-528.16%-2,849.16%-2,482.31%-307.61%
Interest Coverage Ratio (QoQ)Interest Cover (QoQ) 50.24%73.14%-45.34%-684.84%-105.00%-26.11%-27.27%-23.88%
Return on Assets [ROA] (QoQ)ROA (QoQ) -18526.009,887.0010,239.00

Liminatus Pharma Growth Metrics API

Pull Liminatus Pharma's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=LIMN&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY